Last updated 2026-08-06
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Pre-Seed, Seed, Early Stage
About
Boaz Dotan is a co-founder of Amdocs, an Israeli-founded customer-experience and billing-systems software company. He was central to the early product, technical, and commercial development of Amdocs, which went public on Nasdaq in 1998. Following his time at Amdocs, Dotan has been active in various Israeli investment and operating roles, including as a Partner at AfterDox Ltd. and a Director at Innovalve Bio Medical Ltd.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is Boaz Dotan's primary role in the Israeli tech ecosystem?
- Boaz Dotan is a foundational figure in Israeli enterprise-software history, co-founding Amdocs and later becoming active in Israeli investment and operating roles.
- What is Boaz Dotan's background in the software industry?
- Boaz Dotan co-founded Amdocs, an Israeli-founded customer-experience and billing-systems software company, and was central to its early product, technical, and commercial development. Amdocs went public on Nasdaq in 1998.
- What are Boaz Dotan's typical investment stages?
- Boaz Dotan typically invests in Pre-Seed, Seed, and Early Stage companies.
- What are Boaz Dotan's preferred investment sectors?
- Boaz Dotan prefers to invest in Telecommunications, Internet, Advertising, IT, Corporate Software, Security, and Health Technology sectors.
- What is Boaz Dotan's preferred investment geography?
- Boaz Dotan primarily focuses on investments within Israel.
- What is the typical check size for Boaz Dotan's investments?
- Boaz Dotan's typical check size ranges from $100,000 to $500,000.
- What is Boaz Dotan's current operational involvement?
- Boaz Dotan is currently a Partner at AfterDox Ltd. and a Director at Innovalve Bio Medical Ltd.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 1 |
|---|